These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11243498)

  • 1. Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
    Dursun SM; Devarajan S
    Psychopharmacology (Berl); 2001 Feb; 153(4):497-8. PubMed ID: 11243498
    [No Abstract]   [Full Text] [Related]  

  • 2. Citalopram versus other anti-depressive agents for depression.
    Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD006534. PubMed ID: 22786497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curvaceous model of recovery from depression.
    Livingston MG; Clark A
    Lancet; 1997 Feb; 349(9050):447. PubMed ID: 9040570
    [No Abstract]   [Full Text] [Related]  

  • 4. Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
    Sterr A; Padberg F; Amann B; Mergl R; Mulert C; Juckel G; Hegerl U; Pogarell O
    J Clin Psychiatry; 2006 Feb; 67(2):325-6. PubMed ID: 16566633
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression in adults.
    Geddes J; Butler R; Hatcher S; Cipriani A; Price J; Carney S; Von Korff M
    Clin Evid; 2006 Jun; (15):1366-406. PubMed ID: 16973054
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid onset of antidepressant activity with venlafaxine.
    Weisler RH; van Meter S
    J Clin Psychiatry; 2002 Jun; 63(6):534-5; author reply 535-6. PubMed ID: 12088168
    [No Abstract]   [Full Text] [Related]  

  • 7. Addition of olanzapine for treatment-resistant depression.
    Pitchot W; Ansseau M
    Am J Psychiatry; 2001 Oct; 158(10):1737-8. PubMed ID: 11579017
    [No Abstract]   [Full Text] [Related]  

  • 8. A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.
    Wade AG; Toumi I; Hemels ME
    Curr Med Res Opin; 2005 Apr; 21(4):631-42. PubMed ID: 15899113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of venlafaxine in comparison with other antidepressants.
    Lecrubier Y
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():29-35. PubMed ID: 7622815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine-fluoxetine interaction.
    Benazzi F
    J Clin Psychopharmacol; 1999 Feb; 19(1):96-8. PubMed ID: 9934950
    [No Abstract]   [Full Text] [Related]  

  • 11. Update: A 75-year-old man with depression.
    Burns RB; Hartman EE
    JAMA; 2004 Mar; 291(10):1260. PubMed ID: 15010449
    [No Abstract]   [Full Text] [Related]  

  • 12. Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report.
    Bader GM; Hawley JM; Short DD
    J Clin Psychopharmacol; 1998 Jun; 18(3):255-6. PubMed ID: 9617988
    [No Abstract]   [Full Text] [Related]  

  • 13. Three new antidepressants.
    Drug Ther Bull; 1996 Sep; 34(9):65-8. PubMed ID: 8885497
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidepressant effectiveness in severe depression and melancholia.
    Schatzberg AF
    J Clin Psychiatry; 1999; 60 Suppl 4():14-21; discussion 22. PubMed ID: 10086479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
    Bould H; Wiles N; Potokar J; Cowen P; Nutt DJ; Peters TJ; Lewis G
    J Psychopharmacol; 2012 May; 26(5):663-9. PubMed ID: 22223618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
    Kent JM
    Lancet; 2000 Mar; 355(9207):911-8. PubMed ID: 10752718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
    Bertolín-Guillén JM; Climent-Díaz B; Navarré-Gimeno A
    Eur Psychiatry; 2004 Nov; 19(7):456-7. PubMed ID: 15504661
    [No Abstract]   [Full Text] [Related]  

  • 18. A 75-year-old man with depression.
    Kroenke K
    JAMA; 2002 Mar; 287(12):1568-76. PubMed ID: 11911760
    [No Abstract]   [Full Text] [Related]  

  • 19. Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
    Fatemi SH; Emamian ES; Kist DA
    Ann Pharmacother; 1999 Jun; 33(6):701-3. PubMed ID: 10410184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine: a new antidepressant drug.
    Holdcroft C
    Nurse Pract; 1994 Sep; 19(9):21. PubMed ID: 7816367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.